Journal Basic Info

  • Impact Factor: 2.709**
  • H-Index: 11 
  • ISSN: 2474-1663
  • DOI: 10.25107/2474-1663
**Impact Factor calculated based on Google Scholar Citations. Please contact us for any more details.

Major Scope

  •  Ovarian Cancer
  •  Colon Cancer
  •  Pancreatic Cancer
  •  Colorectal Cancer
  •  Immunotherapy
  •  Thoracic Oncology
  •  Hormone Therapy
  •  Sarcomas

Abstract

Citation: Clin Oncol. 2017;2(1):1180.DOI: 10.25107/2474-1663.1180

The Addition of 18F-FDG PET/CT in the Assessment of Indeterminate Adrenal Incidentalomas

Scott Assen, Denise Chan and Janice L Pasieka

Department of Surgery, University of Calgary, Canada
Department of Radiology, University of Calgary, Canada

*Correspondance to: Janice L Pasieka 

 PDF  Full Text Case Report | Open Access

Abstract:

Adrenal masses are common and their management has been the subject of some scrutiny. Initial workup consists of history and physical examination, biochemical evaluation, and imaging, typically using CT or MRI. Some lesions are convincingly benign-appearing on initial imaging and their management typically consists of routine follow-up or laparoscopic resection if the lesion is functional. Others possess imaging characteristics concerning for adrenal cortical carcinoma, such as size >4 cm, heterogeneity, central necrosis or calcifications. For lesions with one or more of these characteristics, the use of 18F-FDG PET/CT is currently unclear in the literature. We propose a novel algorithm utilizing PET/CT for the assessment of indeterminate adrenal masses. We recommend using PET/CT to distinguish lesions that can followed from those that can be resected endoscopic ally and those for which an open surgical approach should be used.

Keywords:

Cite the Article:

Assen S, Chan D, Pasieka JL. The Addition of 18F-FDG PET/CT in the Assessment of Indeterminate Adrenal Incidentalomas. Clin Oncol. 2017;2: 1180.

Search Our Journal

Journal Indexed In

Articles in PubMed

Metastatic Retroperitoneal Paraganglioma: Case Report and Review of the Literature
 PubMed  PMC  PDF  Full Text
LINGO-1 is a New Therapy Target and Biomarker for Ewing Sarcoma
 PubMed  PMC  PDF  Full Text
View More...

Articles with Grants

Examination of the Efficacy of Fulvestrant 500 mg Targeting Estrogen Receptor-Positive Postmenopausal Metastatic Breast Cancer: Prospective Observational Study (PerSeUS BC03 Study)
 Abstract  PDF  Full Text
Expression of the Oncoprotein E5 from Human papillomavirus and miR-203 in Pre-Cancer Lesions and Cervical Cancer
 Abstract  PDF  Full Text
View More...